Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Recruiting now · Phase 1

Conditions studied: Advanced Solid Tumor, Uveal Melanoma, Metastatic, Cutaneous Melanoma

In brief

The Phase I trial is evaluating safety, tolerability, pharmacokinetics and preliminary efficacy of MBS8(1V270) in subjects with advanced solid tumours. The trial is designed to provide data for further clinical development of MBS8(1V270)

Key facts

Study ID

NCT04855435

Run by

MonTa Biosciences ApS

People needed

106

Starts

2021-04-12

Expected to finish

2027-06-01

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Herlev and Gentofte Hospital, Center for Cancer Research — Herlev, Denmark (enrolling)
• Institut Catalá de Oncologia - Hospital Duran i Reynals. — Barcelona, Spain (enrolling)
• Fundacion Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (FJD) — Madrid, Spain (enrolling)
• Centro Integral Oncológico Clara Campal (CIOCC) — Madrid, Spain (enrolling)
• Consorcio Hospital General Universitario de Valencia — Valencia, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.